We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Biomarkers for Tuberculosis Explored

By LabMedica International staff writers
Posted on 25 Dec 2018
Print article
Image: The Simoa HD-1 Analyzer is a fully automated instrument for running immunoassays (Photo courtesy of Quanterix).
Image: The Simoa HD-1 Analyzer is a fully automated instrument for running immunoassays (Photo courtesy of Quanterix).
The gold standard for tuberculosis (TB) diagnosis is the isolation in culture of Mycobacterium tuberculosis in biological samples. However, culture is time consuming and does not accomplish the need of quickly and properly starting treatment, it is not always feasible in extra-pulmonary TB and it is difficult to carry out in resource-limited settings.

To predict the efficacy of anti-TB therapy, sputum conversion after two months of specific treatment is widely used in culture positive TB cases, though simpler and more rapid diagnostic assays would be useful. Therefore, identification of new biomarkers for TB diagnosis and therapy monitoring will provide powerful tools to defeat TB.

In chronic hepatitis, patients not responding to interferon/ribavirin treatment had high levels of an antagonist form of Interferon gamma-induced protein 10 (IP-10). Recently, antagonist IP-10 has been shown to be involved also in TB pathogenesis.

A team of scientists led by the Lazzaro Spallanzani National Institute for Infectious Diseases (Rome Italy) enrolled 33 patients with active TB, 11 patients with pneumonia (either bacterial or viral) and 17 healthy donors (HD) between November 2014 and December 2016. Due to technical problems the analysis was performed on 58 subjects: 32 patients with active TB, 10 patients with pneumonia and 16 HD.

Spot morning urine samples were collected, then transferred to protease-inhibitor tubes, aliquoted in 1 mL tubes and stored at −80 °C until use. Thawed urine samples were centrifuged at 10,000 g for 10 minutes at 4 °C, diluted 1:3 and tested for all forms of IP-10 (total IP-10), agonist IP-10 (long IP-10, 1-77 CXCL10) and antagonist IP-10 (short IP-10, 3-77 CXCL10) using in-house SIMOA ultrasensitive digital enzyme-linked immunosorbent assay (ELISA). Creatinine was measured to normalize IP-10 levels using a BioAssay Systems Quantichrom photometric assay and IP-10 levels were expressed as mg/g.

The scientists found that patients with active TB had significantly higher levels of total and agonist IP-10 at baseline compared to HD; conversely, no differences were observed between IP-10 levels in active TB versus pneumonia. Moreover, in active TB a decline of total urine IP-10 was observed at therapy completion; agonist/antagonist forms reflected this decline although their differences were not statistically significant.

The authors concluded that they showed for the first time that agonist/antagonist IP-10 forms are measurable in urine. IP-10 levels associate with TB and pneumonia disease, suggesting their association with acute inflammation. Further studies are needed to assess their role to monitor TB treatment efficacy. The study was published in the January 2019 issue of the International Journal of Infectious Diseases.

Related Links:
Lazzaro Spallanzani National Institute for Infectious Diseases

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.